Advanced Life Sciences to Be Featured at BIO Mid-America VentureForum 2003

Woodridge, Ill, April 1, 2003 - Advanced Life Sciences, Inc. has been invited to present to the 2003 BIO Mid-America VentureForum in Chicago on Thursday, April 3, as one of the Midwest's top biotechnology and life sciences firms.

Michael T. Flavin, Ph.D., Chief Executive Officer of Advanced Life Sciences will give the presentation at 2:00 PM (CST) at the Hotel Inter-Continental before an audience of investors, analysts, biotech CEOs, journalists and representatives of large pharmaceutical companies.

The BIO Mid-America VentureForum is a collaboration between eight states and the Biotechnology Industry Organization with a focus on funding and investment opportunities for start-up biotech entrepreneurs and seed stage investors in the Midwest Life Sciences area. The conference will showcase the most promising seed, early- and late-stage biotech product and platform companies who are looking for various stages of investment support.

"This event represents a key networking opportunity for investment-seeking biotech companies, like Advanced Life Sciences, to showcase their technologies before an audience of investors, analysts, biotech CEOs, journalists and representatives of large pharmaceutical companies also from the Midwest", said Dr. Flavin.

Based in Woodridge, Illinois, Advanced Life Sciences, Inc. (www.advancedlifesciences.com) is a privately held biopharmaceutical company that discovers and develops therapeutic compounds to fight infection, inflammation and cancer. The company bridges the gap between drug discovery and pharmaceutical commercialization, and focuses on diseases that have significant unmet medical needs in important markets.

###